Literature DB >> 9011616

Possible involvement of glucocorticoids in the modulation of interleukin-1-induced cardiovascular responses in rats.

T Watanabe1, N Tan, Y Saiki, T Makisumi, S Nakamura.   

Abstract

1. In freely moving rats, we investigated whether glucocorticoids modulate the cardiovascular responses to intraperitoneal (I.P.) injection of interleukin-1 beta (IL-1 beta). 2. A lower dose of IL-1 beta (1 microgram kg-1, I.P.) induced monophasic increases, and a higher dose (10 micrograms kg-1, I.P.) induced biphasic increases in both blood pressure and heart rate. Plasma concentration of corticosterone increased significantly after injection of IL-1 beta (10 micrograms kg-1). 3. Systemic pretreatment with an exogenous glucocorticoid, dexamethasone (DEX; 0.5 mg kg-1) reduced the monophasic pressor response, the first phase of the biphasic pressor response and also the initial tachycardia. By contrast, the second phase of the biphasic pressor response was enhanced. 4. After bilateral adrenalectomy, the IL-1 beta (10 micrograms kg-1)-induced pressor effect was reduced; it was restored by treatment with DEX (0.5 mg kg-1). The heart rate response was enhanced in adrenalectomized (ADX) rats; this enhancement was attenuated by DEX. 5. IL-1 beta (10 micrograms kg-1)-induced increases in plasma noradrenaline (NA) were suppressed in intact rats pretreated with DEX (0.5 mg kg-1). The IL-1 beta-induced NA response was greater in ADX rats than in sham-ADX rats. 6. We suggest that glucocorticoids are an important modulator of cardiovascular responses induced in rats by systemically administered IL-1 beta.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9011616      PMCID: PMC1158774          DOI: 10.1113/jphysiol.1996.sp021211

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  21 in total

1.  Effects of interleukin-1 beta on blood pressure, sympathetic nerve activity, and pituitary endocrine functions in anesthetized rats.

Authors:  H Takahashi; M Nishimura; M Sakamoto; I Ikegaki; T Nakanishi; M Yoshimura
Journal:  Am J Hypertens       Date:  1992-04       Impact factor: 2.689

2.  Corticotropin-releasing factor: effects on the autonomic nervous system and visceral systems.

Authors:  M R Brown; L A Fisher
Journal:  Fed Proc       Date:  1985-01

Review 3.  Glucocorticoid hormone action: an overview.

Authors:  J D Baxter; G G Rousseau
Journal:  Monogr Endocrinol       Date:  1979

4.  A rapid and simple procedure for chronic cannulation of the rat jugular vein.

Authors:  P G Harms; S R Ojeda
Journal:  J Appl Physiol       Date:  1974-03       Impact factor: 3.531

5.  Cardiovascular effects of human recombinant interleukin-1 beta in conscious rats.

Authors:  A Bataillard; J Sassard
Journal:  Am J Physiol       Date:  1994-04

6.  Effect of a central CRF antagonist on cardiovascular and thermoregulatory responses induced by stress or IL-1 beta.

Authors:  T Nakamori; A Morimoto; N Murakami
Journal:  Am J Physiol       Date:  1993-10

7.  Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.

Authors:  R G Kilbourn; S S Gross; R F Lodato; J Adams; R Levi; L L Miller; L B Lachman; O W Griffith
Journal:  J Natl Cancer Inst       Date:  1992-07-01       Impact factor: 13.506

8.  Comparison of the effects of intra-third ventricular administration of interleukin-1 or platelet activating factor on ACTH secretion and the sympathetic-adrenomedullary system in conscious rats.

Authors:  K Hashimoto; R Hirasawa; S Makino
Journal:  Acta Med Okayama       Date:  1993-02       Impact factor: 0.892

Review 9.  The role of glucocorticoid hormones as biological amplifiers.

Authors:  D K Granner
Journal:  Monogr Endocrinol       Date:  1979

10.  Hypothalamic sites for cardiovascular and sympathetic modulation by prostaglandin E2.

Authors:  G Feuerstein; S A Adelberg; I J Kopin; D M Jacobowitz
Journal:  Brain Res       Date:  1982-01-14       Impact factor: 3.252

View more
  2 in total

1.  Delayed protection against ischaemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxin.

Authors:  W Song; B L Furman; J R Parratt
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

2.  SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation.

Authors:  Takafumi Toyohara; Takehiro Suzuki; Ryo Morimoto; Yasutoshi Akiyama; Tomokazu Souma; Hiromi O Shiwaku; Yoichi Takeuchi; Eikan Mishima; Michiaki Abe; Masayuki Tanemoto; Satohiro Masuda; Hiroaki Kawano; Koji Maemura; Masaaki Nakayama; Hiroshi Sato; Tsuyoshi Mikkaichi; Hiroaki Yamaguchi; Shigefumi Fukui; Yoshihiro Fukumoto; Hiroaki Shimokawa; Ken-ichi Inui; Tetsuya Terasaki; Junichi Goto; Sadayoshi Ito; Takanori Hishinuma; Isabelle Rubera; Michel Tauc; Yoshiaki Fujii-Kuriyama; Hikaru Yabuuchi; Yoshinori Moriyama; Tomoyoshi Soga; Takaaki Abe
Journal:  J Am Soc Nephrol       Date:  2009-10-29       Impact factor: 10.121

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.